Yahoo Web Search

Search results

  1. 1 day ago · Haleon has agreed to sell its nicotine replacement therapy business outside the US for £500mn, the latest in a string of disposals of its slower-growth brands since the consumer health group was ...

  2. 21 hours ago · Haleon will sell its nicotine replacement therapy business outside the U.S. to a unit of India's Dr. Reddy's for 500 million pounds ($632.55 million), the British consumer healthcare company said ...

  3. 1 day ago · Jon Robinson. UK Editor. The deal is expected to complete later in 2024. Haleon, the maker of Sensodyne toothpaste, has agreed a £500m deal to sell a major division outside of the US. The company ...

  4. 12 hours ago · Healthcare giant Haleon is offloading the nicotine replacement brands it sells outside the US for £500million. Indian pharmaceutical company Dr Reddy’s Laboratories is taking on products ...

  5. 1 day ago · Haleon floated on the London Stock Exchange with a value of more than £30 billion (Haleon/PA) Anna Wise 4 minutes ago. Sensodyne and Panadol maker Haleon has agreed to sell its nicotine ...

  6. 1 day ago · Haleon will be selling the unit to Dr Reddy's for GBP500 million. This is structured as an upfront cash payment of GBP458 million, with a further up to GBP42 million deferred performance-based ...

  7. 1 day ago · Haleon has continued its push to divest, selling its nicotine replacement therapy (NRT) business outside of the United States to Dr. Reddy’s for 500 million pounds ($633 million). The unit ...

  8. People also ask

  1. People also search for